Estradiol intranasal

Drug Profile

Estradiol intranasal

Alternative Names: Aerodiol; Estradiol hemihydrate - Servier; S21400

Latest Information Update: 20 Jan 2011

Price : $50

At a glance

  • Originator Servier
  • Class Antineoplastics; Estradiol congeners; Estrenes; Hormonal replacements; Small molecules
  • Mechanism of Action Estrogen receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Market Withdrawal Menopausal syndrome

Most Recent Events

  • 20 Aug 2013 Biomarkers information updated
  • 08 Jan 2003 A study has been added to the adverse events and Women's Health therapeutic trials sections
  • 15 Nov 2001 Launched for Menopausal syndrome in Ireland (Intranasal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top